The specialists at Praedicare came out of a global health and neglected health background in academia where they were full professors, and as drug developers in biotech companies that developed anti-infectives for tuberculosis, parasitic diseases, non-tuberculous mycobacteria, leprosy, HIV, hepatitis C, and the global problem of developing dosing regimens in an increasingly obese world. We have partnered with international public/private organizations, biotech companies, pharmaceutical companies, governmental funding bodies, and several universities to develop treatments.